CYP7B1 Antibody (Rabbit mAb) [M6P12]

CatNo: F3601

    Application: Reactivity:
    • Lane 1: PC-3, Lane 2: A431
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    60秒以上の露光(暴露)を推奨します。

    使用情報

    Dilution
    1:1000 - 1:10000
    Application
    WB
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    58 kDa 55 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human fetal liver; Human fetal kidney; PC3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

    Datasheet & SDS

    生物学的記述

    Specificity
    CYP7B1 Antibody (Rabbit mAb) [M6P12] detects endogenous levels of total CYP7B1 protein.
    タンパク質の局在
    小胞体、細胞内膜系、ミクロソーム
    Uniprot ID
    O75881
    Clone
    M6P12
    Synonym(s)
    Cytochrome P450 7B1, 24-hydroxycholesterol 7-alpha-hydroxylase, 25/26-hydroxycholesterol 7-alpha-hydroxylase, 3-hydroxysteroid 7-alpha hydroxylase, Oxysterol 7-alpha-hydroxylase, CYP7B1
    Background
    CYP7B1 is a microsomal cytochrome P450 monooxygenase that acts as an oxysterol and steroid 7α‑hydroxylase, catalyzing the NADPH‑dependent insertion of oxygen at the 7α (and in some cases 6α) position of diverse cholesterol‑derived substrates and thereby linking oxysterol, neurosteroid, and bile acid metabolism. The enzyme is expressed in liver and in multiple steroidogenic or steroid‑responsive tissues including brain, testis, ovary, prostate, kidney, and intestine, where it hydroxylates oxysterols such as 25‑hydroxycholesterol, 27‑hydroxycholesterol, and cholest-5-ene-3β,25-diol, as well as neurosteroids like dehydroepiandrosterone and pregnenolone, with structural requirements that include a 3β‑hydroxy group, a polar substituent at C17, and absence of additional side‑chain hydroxyls beyond C20–C24. In extrahepatic tissues, CYP7B1 initiates a cholesterol catabolic route by converting oxysterols to 7α‑hydroxy derivatives that can be transported to the liver and further metabolized to bile acids, providing an “alternative” bile acid synthesis pathway complementary to the classic CYP7A1‑dependent route; in the immune system, the CYP7B1 product 7α,25‑dihydroxycholesterol functions as a high‑affinity ligand for the chemotactic receptor GPR183/EBI2 and guides B‑cell positioning within germinal centers, directly coupling CYP7B1 activity to humoral immune architecture. In the brain, CYP7B1 hydroxylates neuroactive steroids and oxysterols, modulating their signaling via nuclear receptors and helping to maintain cholesterol and neurosteroid balance, and Cyp7b1‑null mice display loss of oxysterol 7α‑hydroxylation in liver and brain along with altered levels of multiple oxysterols, indicating that this enzyme is the major 7α‑hydroxylase for these substrates in vivo. Human loss‑of‑function CYP7B1 mutations cause autosomal recessive hereditary spastic paraplegia type 5, where biochemical studies document accumulation of 25‑ and 27‑hydroxycholesterol and related cholestenoic acids, and clinical cohorts show both pure and complicated spastic paraplegia phenotypes with variable white‑matter changes, supporting a pathogenic link between impaired CYP7B1‑mediated detoxification of oxysterols, disturbed bile acid and neurosteroid metabolism, and long‑tract motor neuron degeneration.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください